Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 5, Pages e61532
Publisher
Public Library of Science (PLoS)
Online
2013-05-02
DOI
10.1371/journal.pone.0061532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alkylation of Cysteine 468 in Stat3 Defines a Novel Site for Therapeutic Development
- (2011) Ralf Buettner et al. ACS Chemical Biology
- Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression
- (2011) Akihisa Fukuda et al. CANCER CELL
- Stat3/Socs3 Activation by IL-6 Transsignaling Promotes Progression of Pancreatic Intraepithelial Neoplasia and Development of Pancreatic Cancer
- (2011) Marina Lesina et al. CANCER CELL
- Phospho-Sulindac (OXT-328) Combined with Difluoromethylornithine Prevents Colon Cancer in Mice
- (2011) Gerardo G. Mackenzie et al. Cancer Prevention Research
- Mitochondrial-targeted Signal Transducer and Activator of Transcription 3 (STAT3) Protects against Ischemia-induced Changes in the Electron Transport Chain and the Generation of Reactive Oxygen Species
- (2011) Karol Szczepanek et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion
- (2010) Kerstin Boengler et al. BASIC RESEARCH IN CARDIOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma
- (2010) Harvey J. Mamon et al. CANCER
- Phospho-Sulindac (OXT-328), a Novel Sulindac Derivative, Is Safe and Effective in Colon Cancer Prevention in Mice
- (2010) Gerardo G. Mackenzie et al. GASTROENTEROLOGY
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Disruption of Astrocyte STAT3 Signaling Decreases Mitochondrial Function and Increases Oxidative Stress In Vitro
- (2010) Theodore A. Sarafian et al. PLoS One
- Dual role of the receptor Tom20 in specificity and efficiency of protein import into mitochondria
- (2010) H. Yamamoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phosphoaspirin (MDC-43), a novel benzyl ester of aspirin, inhibits the growth of human cancer cell lines more potently than aspirin: a redox-dependent effect
- (2009) W. Zhao et al. CARCINOGENESIS
- The basal flux of Akt in the mitochondria is mediated by heat shock protein 90
- (2009) Keri A. Barksdale et al. JOURNAL OF NEUROCHEMISTRY
- The Role of STAT-3 in the Induction of Apoptosis in Pancreatic Cancer Cells by Benzyl Isothiocyanate
- (2009) R. P. Sahu et al. JNCI-Journal of the National Cancer Institute
- A Novel Combination Therapy With Arsenic Trioxide and Parthenolide Against Pancreatic Cancer Cells
- (2009) Wei Wang et al. PANCREAS
- Mitochondrial STAT3 Supports Ras-Dependent Oncogenic Transformation
- (2009) D. J. Gough et al. SCIENCE
- Function of Mitochondrial Stat3 in Cellular Respiration
- (2009) J. Wegrzyn et al. SCIENCE
- GABAB receptor is a novel drug target for pancreatic cancer
- (2007) Hildegard M. Schuller et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now